SCHEMBL4935236

SCHEMBL4935236

Cc1ccc(S(=O)(=O)Nc2ccc(CC(N)C(=O)NO)cc2)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.60
HDAC1 Q13547 5/20 0.59
HPGD P15428 2/20 0.56
MAPT P10636 2/20 0.56
LMNA P02545 4/20 0.55
MEN1 O00255 3/20 0.55
KMT2A Q03164 3/20 0.55
SMN1; SMN2 Q16637 2/20 0.55
GHSR Q92847 1/20 0.53
HDAC4 P56524 4/20 0.52
HDAC8 Q9BY41 3/20 0.52
HDAC3 O15379 2/20 0.51
HDAC7 Q8WUI4 2/20 0.51
HDAC2 Q92769 2/20 0.51
HDAC10 Q969S8 2/20 0.51
HDAC11 Q96DB2 2/20 0.51
HDAC6 Q9UBN7 2/20 0.51
HDAC9 Q9UKV0 2/20 0.51
HDAC5 Q9UQL6 2/20 0.51
ALOX12 P18054 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4935233 1.00 ALDH1A1 (0.60) ALDH1A1HDAC1HPGDMAPTLMNA
SCHEMBL14422985 0.87 ALDH1A1 (0.66) ALDH1A1HDAC1HPGDMAPTLMNA
SCHEMBL5607923 0.87 ALDH1A1 (0.66) ALDH1A1HDAC1HPGDMAPTLMNA
SCHEMBL25095198 0.84 LMNA (0.63) ALDH1A1HDAC1HPGDMAPTLMNA
SCHEMBL4927379 0.79 FFAR1 (0.56) ALDH1A1HDAC1HPGDMAPTLMNA
SCHEMBL4927385 0.79 FFAR1 (0.56) ALDH1A1HDAC1HPGDMAPTLMNA
SCHEMBL2691033 0.78 HDAC1 (0.74) ALDH1A1HDAC1HPGDMAPTLMNA
SCHEMBL4932964 0.77 NPC1 (0.58) ALDH1A1HDAC1HPGDMAPTLMNA
SCHEMBL4932973 0.77 NPC1 (0.58) ALDH1A1HDAC1HPGDMAPTLMNA
SCHEMBL31689516 0.76 ALDH1A1 (0.51) ALDH1A1HDAC1HPGDMAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080132539-A1 Hydroxamic Acid Derivative And Age Generation Inhibitor Containing The Derivative KUREHA CORPORATION (JP) 2008-06-05 US disclosed
EP-1707560-A1 HYDROXAMIC ACID DERIVATIVE AND AGE GENERATION INHIBITOR CONTAINING THE DERIVATIVE Kureha Corporation (JP) 2006-10-04 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080132539-A1 Hydroxamic Acid Derivative And Age Generation Inhibitor Containing The Derivative HDAC5, HDAC1, HDAC9 ALDH1A1 1829/4885HDAC1 2/4885HPGD 65/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.